Cargando…
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome
People with cystic fibrosis (pwCF) experience a range of persistent gastrointestinal symptoms throughout life. There is evidence indicating interaction between the microbiota and gut pathophysiology in CF. However, there is a paucity of knowledge on the potential effects of CF transmembrane conducta...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581179/ https://www.ncbi.nlm.nih.gov/pubmed/37607068 http://dx.doi.org/10.1128/spectrum.01175-23 |